265 related articles for article (PubMed ID: 16735295)
1. Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS.
Degenhardt L; Hall W; Warner-Smith M
Sex Transm Infect; 2006 Jun; 82 Suppl 3(Suppl 3):iii56-63. PubMed ID: 16735295
[TBL] [Abstract][Full Text] [Related]
2. A multicentre study on the causes of death among Italian injecting drug users. AIDS has overtaken overdose as the principal cause of death.
Mezzelani P; Quaglio GL; Venturini L; Lugoboni F; Friedman SR; Des Jarlais DC
AIDS Care; 1998 Feb; 10(1):61-7. PubMed ID: 9536202
[TBL] [Abstract][Full Text] [Related]
3. Mortality from overdose among injecting drug users recently released from prison: database linkage study.
Seaman SR; Brettle RP; Gore SM
BMJ; 1998 Feb; 316(7129):426-8. PubMed ID: 9492665
[TBL] [Abstract][Full Text] [Related]
4. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users.
Zaccarelli M; Gattari P; Rezza G; Conti S; Spizzichino L; Vlahov D; Ippolito G; Lelli V; Valenzi C
AIDS; 1994 Mar; 8(3):345-50. PubMed ID: 8031512
[TBL] [Abstract][Full Text] [Related]
5. [Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy].
Muga R; Egea JM; Navío M; Sirera G; Vall M; Tor J
Med Clin (Barc); 1999 May; 112(19):721-5. PubMed ID: 10394568
[TBL] [Abstract][Full Text] [Related]
6. Study of 2708 heroin-related deaths in north-eastern Italy 1985-98 to establish the main causes of death.
Quaglio G; Talamini G; Lechi A; Venturini L; Lugoboni F; Mezzelani P;
Addiction; 2001 Aug; 96(8):1127-37. PubMed ID: 11487419
[TBL] [Abstract][Full Text] [Related]
7. [AIDS-free time and survival of an injecting drug users HIV seroconvertors cohort].
Pérez-Hoyos S; Aviñó M; Hernández I; González J; Ruiz I
Gac Sanit; 1999; 13(5):337-45. PubMed ID: 10564846
[TBL] [Abstract][Full Text] [Related]
8. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
[TBL] [Abstract][Full Text] [Related]
9. The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis.
Hendriks JC; Satten GA; van Ameijden EJ; van Druten HA; Coutinho RA; van Griensven GJ
AIDS; 1998 Aug; 12(12):1537-44. PubMed ID: 9727576
[TBL] [Abstract][Full Text] [Related]
10. The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.
Murray M; Hogg RS; Lima VD; May MT; Moore DM; Abgrall S; Bruyand M; D'Arminio Monforte A; Tural C; Gill MJ; Harris RJ; Reiss P; Justice A; Kirk O; Saag M; Smith CJ; Weber R; Rockstroh J; Khaykin P; Sterne JA;
HIV Med; 2012 Feb; 13(2):89-97. PubMed ID: 21819529
[TBL] [Abstract][Full Text] [Related]
11. Pre-AIDS mortality in the Edinburgh City Hospital HIV cohort.
Seaman SR; Brettle RP; Gore SM
Stat Med; 1997 Nov; 16(21):2459-74. PubMed ID: 9364654
[TBL] [Abstract][Full Text] [Related]
12. Mortality of cohort of very young injecting drug users in Prague, 1996-2010.
Zábranský T; Csémy L; Grohmannová K; Janíková B; Brenza J
Cent Eur J Public Health; 2011 Sep; 19(3):152-7. PubMed ID: 22026292
[TBL] [Abstract][Full Text] [Related]
13. Metropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDS.
Friedman SR; West BS; Pouget ER; Hall HI; Cantrell J; Tempalski B; Chatterjee S; Hu X; Cooper HL; Galea S; Des Jarlais DC
PLoS One; 2013; 8(2):e57201. PubMed ID: 23437341
[TBL] [Abstract][Full Text] [Related]
14. Excess mortality among injection drug users with AIDS, New York City (1999-2004).
Pfeiffer MR; Hanna DB; Begier EM; Sepkowitz KA; Zimmerman R; Sackoff JE
Subst Use Misuse; 2011; 46(2-3):245-53. PubMed ID: 21303244
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
[TBL] [Abstract][Full Text] [Related]
17. AIDS incidence and mortality in injecting drug users: the AjUDE-Brasil II Project.
Cardoso MN; Caiaffa WT; Mingoti SA;
Cad Saude Publica; 2006 Apr; 22(4):827-37. PubMed ID: 16612436
[TBL] [Abstract][Full Text] [Related]
18. Mortality of intravenous drug users living in Milan, Italy: role of HIV-1 infection. COMCAT Study Group.
Galli M; Musicco M
AIDS; 1994 Oct; 8(10):1457-63. PubMed ID: 7818817
[TBL] [Abstract][Full Text] [Related]
19. High mortality among HIV-infected injecting drug users without AIDS diagnosis: implications for HIV infection epidemic modellers?
van Haastrecht HJ; van den Hoek AJ; Coutinho RA
AIDS; 1994 Mar; 8(3):363-6. PubMed ID: 8031515
[TBL] [Abstract][Full Text] [Related]
20. The increasing mortality burden of liver disease among opioid-dependent people: cohort study.
Gibson A; Randall D; Degenhardt L
Addiction; 2011 Dec; 106(12):2186-92. PubMed ID: 21749525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
